Jean-François Pariseau

Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada.

BDC Capital, Inc. provides investment services. It offers services to the corporate and private firm?s. The company is headquartered in Montreal, Canada.

CDP Capital Technology Ventures is a venture capital firm that invests in technology companies. The firm provides funding for companies in various stages of development, from early-stage startups to established businesses. CDP Capital Technology Ventures focuses on companies in the information technology, telecommunications, and life sciences sectors. The firm is a subsidiary of Caisse de dépôt et placement du Québec, one of Canada's largest institutional fund managers, and ultimately controlled by the Province of Québec.

Monteris Medical, Inc. operates as a medical device company that develops laser-based systems to treat brain tumors. It offers the AXiiiS Stereotactic Miniframe, a single use platform for image-guided, stereotactic brain biopsy, and the AtamA Stabilization System for MRI-guided neurosurgical procedures that require rigid head fixation. The company was founded by Mark G. Torchia in 1999 and is headquartered in Winnipeg, Canada.

Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada.

Clearwater Clinical Ltd. designs and manufactures innovative medical-grade devices. It offers medical devices, mobile medicine, endoscope imaging, audiometers, hearing testing and endoscope adaptors. The company was founded by Matthew Bromwich in 2005 and is headquartered in Ottawa, Canada.

Wren House Infrastructure Management Ltd (Wren House Infrastructure) is a private equity arm of Kuwait Investment Authority founded in 2013. The firm is headquartered in London, United Kingdom.

Imagia Cybernetics, Inc. develops and distributes medical image analysis solutions. It offers artificial intelligence for detection, segmentation, follow-up, and classification. The company was founded by Nicolas Chapados and Alexandre Le Bouthillier in 2015 is headquartered in Montreal, Canada.

Meddev Commercialization Centre manufactures medical devices. The private company is based in Ottawa, Canada.

Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada.

LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada.

Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021.